MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
IPO Year: 2020
Exchange: NASDAQ
| Date | Price Target | Rating | Analyst |
|---|
SC 13G - MedTech Acquisition Corp (0001826667) (Subject)
SC 13G - MedTech Acquisition Corp (0001826667) (Subject)
The Company recommends all of its stockholders to vote FOR the Extension Amendment at the upcoming Special Meeting. New York, NY, Dec. 07, 2022 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (NASDAQ:MTAC) ("MedTech" or the "Company") today announced that on December 7, 2022, it convened and then adjourned, without conducting other business, its special meeting of stockholders (the "Special Meeting") in lieu of its 2022 Annual Meeting of Stockholders from December 7, 2022 to 11:00 a.m. Eastern Time on December 12, 2022. The Special Meeting is being adjourned in order to solicit more votes toward the approval to amend the Company's amended and restated certificate of incorporation
OR YEHUDA, Israel, Aug. 19, 2021 /PRNewswire/ -- Peregrine Ventures portfolio company Memic Innovative Surgery Ltd. has entered into a definitive agreement for a business combination with MedTech Acquisition Corporation (NASDAQ:MTAC), a publicly traded special purpose acquisition company (SPAC) focused on medical technology, including surgical robots. Memic is an Israeli based medical device company, founded and grown in Peregrine's incubator, that has developed the Hominis®, a robotic platform for surgical procedures. Following the completion of the business combination transaction – expected in the fourth quarter of 2021 – the combined company will operate under the Memic name with an es
New York, NY, Feb. 05, 2021 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (Nasdaq:MTACU) (the “Company”) announced today that, commencing February 8, 2021, holders of the 25,000,000 units sold in the Company’s initial public offering may elect to separately trade shares of the Company’s Class A common stock and warrants included in the units. The shares of Class A common stock and warrants that are separated will trade on The Nasdaq Capital Market (“Nasdaq”) under the symbols “MTAC” and “MTACW”, respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Those units not separated will continue to trade on Nasdaq under the symbo
8-K - MedTech Acquisition Corp (0001826667) (Filer)
SC 13G - MedTech Acquisition Corp (0001826667) (Subject)